Citation Impact
Citing Papers
Global epidemiology of nonalcoholic fatty liver disease—Meta‐analytic assessment of prevalence, incidence, and outcomes
2015 Standout
Genetic-related and carbohydrate-related factors affecting liver fat accumulation
2012
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer
2015 Standout
Medical and non-medical complications among children and adolescents with excessive body weight
2014
The genomic basis of the Williams – Beuren syndrome
2008
Orally active growth hormone secretagogues: state of the art and clinical perspectives
1998
The complexities of skeletal biology
2003 StandoutNature
Acromegaly
2006 Standout
Occurrence of galanin-like immunoreactivity in growth hormone-releasing factor (GRF)-containing neurons of the monkey (Macaca fascicularis) infundibular nucleus and median eminence
1990
Restoration of the coupling process and normalization of bone mass following successful treatment of endogenous Cushing’s syndrome: A prospective, long-term study
2005
Nephrogenic Diabetes Insipidus
2006
Lymphocytic Thyroiditis on Histology Correlates with Serum Thyroglobulin Autoantibodies in Patients with Papillary Thyroid Carcinoma: Impact on Detection of Serum Thyroglobulin
2012
Delayed graft function in kidney transplantation
2004 Standout
Metabolic Clearance Rates of Synthetic Human Growth Hormone in Children, Adult Women, and Adult Men*
1989
MANAGEMENT OF ENDOCRINE DISEASE: The burden of Cushing's disease: clinical and health-related quality of life aspects
2012
Intravenous Refeeding Blocks Growth Hormone (GH)-Provoked Rises in Serum Free Fatty Acids and Blunting of Somatotroph Response to GH-Releasing Hormone in Normal Men*
1989
Growth Hormone, Exercise, and Aging: The Future of Therapy for the Frail Elderly
1994
Genetic Predisposition in NAFLD and NASH: Impact on Severity of Liver Disease and Response to Treatment
2013
Nutritional Regulation of the Insulin-Like Growth Factors*
1994
Hexarelin, a potent GHRP analogue: Interactions with GHRH and clonidine in young and aged dogs
1995
Is Caregiving Hazardous to One's Physical Health? A Meta-Analysis.
2003 Standout
Genetic modifiers of non-alcoholic fatty liver disease progression
2011
Anatomy and regulation of the central melanocortin system
2005 Standout
The GH, prolactin, ACTH and cortisol responses to Hexarelin, a synthetic hexapeptide, undergo different age-related variations
1997
Peptide‐ and transmitter‐containing neurons in the mediobasal hypothalamus and their relation to GABAergic systems: Possible roles in control of prolactin and growth hormone secretion
1988
Effect of galanin on growth hormone-releasing hormone-stimulated growth hormone secretion in adult patients with nonendocrine diseases on long-term daily glucocorticoid treatment
1992
Gonadal steroid hormone regulation of the somatotropic axis during puberty in humans
1994
Metabolic regulation of growth hormone by free fatty acids, somatostatin, and ghrelin in HIV-lipodystrophy
2004
The β-Thalassemias
1999 Standout
Interaction of glucose and pyridostigmine on the secretion of growth hormone (GH) induced by GH-releasing hormone (GHRH)
1990
PNPLA3 I148M (rs738409) genetic variant is associated with hepatocellular carcinoma in obese individuals
2012
Co-Localization of Growth Hormone Secretagogue Receptor and NPY mRNA in the Arcuate Nucleus of the Rat
1999
Free insulin-like growth factors in human obesity
1995
Serum Insulin-Like Growth Factor I Reference Values for an Automated Chemiluminescence Immunoassay System: Results from a Multicenter Study
2003
Functional Selectivity and Classical Concepts of Quantitative Pharmacology
2006 StandoutNobel
Galanin counteracts the inhibitory effects of glucocorticoids on growth hormone secretion in the rat
1995
Cushing's syndrome
2015 Standout
Pnpla3/Adiponutrin deficiency in mice does not contribute to fatty liver disease or metabolic syndrome
2010
Interaction of salbutamol with pyridostigmine and arginine on both basal and GHRH‐stimulated GH secretion in humans
1994
Effect of the combined administration of galanin and clonidine on serum growth hormone levels in normal subjects and in patients under chronic glucocorticoid treatment
1994
Medical Treatment of Cushing's Disease
2013
Effect of Galanin on the Growth Hormone (GH) Response to Ghreleasing Hormone in Patients with Cushing's Disease
1993
Diagnosis and management of medical problems in adults with Williams–Beuren syndrome
2007
Galanin
1991
Endocrine and Non-Endocrine Activities of Growth Hormone Secretagogues in Humans
1999
Clinical Practice Guideline for Screening and Management of High Blood Pressure in Children and Adolescents
2017 Standout
The adolescent brain and age-related behavioral manifestations
2000 Standout
Persistence of Increased Cardiovascular Risk in Patients with Cushing’s Disease after Five Years of Successful Cure
1999
Survivors of childhood and adolescent cancer: life-long risks and responsibilities
2013 Standout
Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism
2009
Pyridostigmine-mediated growth hormone release: evidence for somatostatin involvement.
1992
Increased prevalence of thyroid autoimmunity in patients successfully treated for Cushing's disease
2000
Growth Hormone (GH) Autofeedback on GH Response to GH-Releasing Hormone. Role of Free Fatty Acids and Somatostatin
1991
Growth hormone deficiency and vascular risk
2002
The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population
2011
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Improved Quality of Life After Bilateral Laparoscopic Adrenalectomy for Cushing's Disease
2007
Mechanisms of NAFLD development and therapeutic strategies
2018 Standout
Adrenergic and cholinergic involvement in basal and growth hormone-releasing hormone-stimulated growth hormone secretion in glucocorticoid-treated rats
1995
The Somatotropic Axis in Critical Illness: Effect of Continuous Growth Hormone (GH)-Releasing Hormone and GH-Releasing Peptide-2 Infusion1
1997
Anatomy and physiology of central galanin-containing pathways
1993
Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms
2004 Standout
Non-alcoholic fatty liver disease
2021 Standout
Williams–Beuren Syndrome
2010 Standout
Relative effects of estrogen, age, and visceral fat on pulsatile growth hormone secretion in healthy women
2009
Ghrelin induces adiposity in rodents
2000 StandoutNature
Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
2011
Neuromodulatory Role of Opioidergic System on Hypothalamus—Pituitary—Gonadal Axis during Puberty
1997
Hypercortisolism and Obesity
1995
Endogenous growth hormone (GH)-releasing hormone is required for GH responses to pharmacological stimuli.
1996
Endocrine Aspects of Obesity
1989
Presenting phenotype and clinical evaluation in a cohort of 22 Williams–Beuren syndrome patients
2007
Galanin Is a Physiological Regulator of Spontaneous Pulsatile Secretion of Growth Hormone in the Male Rat*
1990
A Membrane-proximal Basic Domain and Cysteine Cluster in the C-terminal Tail of CCR5 Constitute a Bipartite Motif Critical for Cell Surface Expression
2001 StandoutNobel
Radiation Therapy in the Multimodal Treatment Approach of Pituitary Adenoma
2002
A role for ghrelin in the central regulation of feeding
2001 StandoutNature
β-Adrenergic Modulation of Growth Hormone (GH) Autofeedback on Sleep-Associated and Pharmacologically Induced GH Secretion*
1989
Growth Hormone Secretagogues: The Clinical Future
1999
Bioactive peptides in anterior pituitary cells
1994
Serum Ghrelin Levels Are Inversely Correlated with Body Mass Index, Age, and Insulin Concentrations in Normal Children and Are Markedly Increased in Prader-Willi Syndrome
2003
Glucose metabolism and visceral fat in GH deficient adults: 1 year of GH replacement
2003
Pyridostigmine treatment selectively amplifies the mass of GH secreted per burst without altering GH burst frequency, half-life, basal GH secretion or the orderliness of GH release
1997
α-Adrenoceptors
1994
The molecular basis of nephrogenic diabetes insipidus
1998
The effects of pituitary stalk transection, hypophysectomy and thyroid hormone status on insulin-like growth factor 2-, growth hormone releasing hormone-, and somatostatin mRNA prevalence in rat brain
1992
PYRIDOSTIGMINE DOES NOT REVERSE DEXAMETHASONE‐INDUCED GROWTH HORMONE INHIBITION
1990
The late growth hormone rise induced by oral glucose is enhanced by cholinergic stimulation with pyridostigmine in normal subjects
1992
Glucose Metabolism and Visceral Fat in GH Deficient Adults: Two Years of GH-Replacement
2004
A Common Variant in the Patatin-Like Phospholipase 3 Gene ( PNPLA3 ) Is Associated with Fatty Liver Disease in Obese Children and Adolescents
2010
ALPHA‐2‐ADRENERGIC PATHWAYS RELEASE GROWTH HORMONE VIA A NON‐GRF‐DEPENDENT MECHANISM IN NORMAL HUMAN SUBJECTS
1988
Role of galanin in the regulation of somatotrope and gonadotrope function in young ovulatory women
1995
Growth Hormone (GH) Insensitivity Due to Primary GH Receptor Deficiency
1994
GROWTH HORMONE NEUROREGULATION AND ITS ALTERATIONS IN DISEASE STATES
1988
NAFLD in Asia—as common and important as in the West
2013
IMPAIRED GROWTH HORMONE RESPONSE TO INSULIN‐INDUCED HYPOGLYCAEMIA IN OBESE PATIENTS: RESTORATION BLOCKED BY RITANSERIN AFTER FENFLURAMINE ADMINISTRATION
1990
Testosterone and Oxandrolone, a Nonaromatizable Androgen, Specifically Amplify the Mass and Rate of Growth Hormone (GH) Secreted per Burst without Altering GH Secretory Burst Duration or Frequency or the GH Half-Life*
1990
Bone mineral density at diagnosis and following successful treatment of pediatric Cushing’s disease
2005
Mechanisms for Insulin Resistance: Common Threads and Missing Links
2012 Standout
Aquaporin water channels – from atomic structure to clinical medicine
2002 StandoutNobel
Advances in Pediatric Nonalcoholic Fatty Liver Disease†
2009
The diagnosis and management of non-alcoholic fatty liver disease: Practice Guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association
2012 Standout
A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction
1998 StandoutNature
Reduced Cell Surface Expression of CCR5 in CCR5Δ32 Heterozygotes Is Mediated by Gene Dosage, Rather Than by Receptor Sequestration
2002 StandoutNobel
Tissue-specific sex differences in galanin-like immunoreactivity and galanin mRNA during development in the rat
1989
Cushing's syndrome
2006 Standout
Adrenal function testing in pediatric cancer survivors
2009
NITRIC OXIDE SYNTHASE ACTIVITY IN RENAL ISCHEMIA-REPERFUSION INJURY IN THE RAT
1997
Differential impact of age, sex steroid hormones, and obesity on basal versus pulsatile growth hormone secretion in men as assessed in an ultrasensitive chemiluminescence assay.
1995
Growth Hormone-Releasing Hexapeptide Is a Potent Stimulator of Growth Hormone Gene Expression and Release in the Growth Hormone—Releasing Hormone—Deprived Infant Rat
1994
Ghrelin: Structure and Function
2005 Standout
Dual Defects in Pulsatile Growth Hormone Secretion and Clearance Subserve the Hyposomatotropism of Obesity in Man*
1991
Effect of two β2-agonist drugs, salbutamol and broxaterol, on the growth hormone response to exercise in adult patients with asthmatic bronchitis
1995
Guidelines for the Treatment of Hypothyroidism: Prepared by the American Thyroid Association Task Force on Thyroid Hormone Replacement
2014 Standout
Nephrogenic Diabetes Insipidus
2001
Pathophysiology of Human Visceral Obesity: An Update
2013 Standout
Pathophysiology of the Neuroregulation of Growth Hormone Secretion in Experimental Animals and the Human*
1998 Standout
Possible Mechanisms Involved in Growth Hormone Secretion Induced by Galanin in the Rat*
1989
The Metabolic Syndrome and Insulin-Like Growth Factor I Regulation in Adolescent Obesity1
1998
The Effects of Growth Hormone Replacement Therapy on Bone Metabolism in Adult-Onset Growth Hormone Deficiency: A 2-Year Open Randomized Controlled Multicenter Trial
2002
Brief Communication: Sleep Curtailment in Healthy Young Men Is Associated with Decreased Leptin Levels, Elevated Ghrelin Levels, and Increased Hunger and Appetite
2004 Standout
Mechanisms of Insulin Action and Insulin Resistance
2018 Standout
A Preprandial Rise in Plasma Ghrelin Levels Suggests a Role in Meal Initiation in Humans
2001 Standout
Suppressed spontaneous and stimulated growth hormone secretion in patients with Cushing's disease before and after surgical cure.
1994
The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
2017 Standout
Dietary and Policy Priorities for Cardiovascular Disease, Diabetes, and Obesity
2016 Standout
Quality of Life and Other Outcomes in Children Treated for Cushing Syndrome
2013
Aquaporin water channels: atomic structure molecular dynamics meet clinical medicine
2002 StandoutNobel
The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1 (IGF-1), IGF-binding protein-3, insulin, and growth hormone
1994
The rs2294918 E434K variant modulates patatin‐like phospholipase domain‐containing 3 expression and liver damage
2015
Subcutaneous and Visceral Adipose Tissue: Their Relation to the Metabolic Syndrome
2000 Standout
Aquaporin water channels: atomic structure molecular dynamics meet clinical medicine
2002 StandoutNobel
Aquaporin water channels: atomic structure molecular dynamics meet clinical medicine
2002 StandoutNobel
Prolactin: Structure, Function, and Regulation of Secretion
2000 Standout
Physiological role of galanin in the regulation of anterior pituitary function in humans
1994
Human Fatty Liver Disease: Old Questions and New Insights
2011 StandoutScience
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Comparison between Insulin-Induced Hypoglycemia and Growth Hormone (GH)-Releasing Hormone + Arginine as Provocative Tests for the Diagnosis of GH Deficiency in Adults1
1998
The Oxytocin Receptor System: Structure, Function, and Regulation
2001 Standout
Galanin is an estrogen-inducible, secretory product of the rat anterior pituitary.
1988
Massive weight loss restores 24-hour growth hormone release profiles and serum insulin-like growth factor-I levels in obese subjects.
1995
Review article: the emerging role of genetics in precision medicine for patients with non‐alcoholic steatohepatitis
2020
Biological, Physiological, Pathophysiological, and Pharmacological Aspects of Ghrelin
2004
Obesity and endocrine disease
2003
INSIGHTS FROM IN VIVO MODIFICATION OF ADRENERGIC RECEPTOR GENE EXPRESSION
1998 StandoutNobel
Adrenal Function in Thalassemia Major Following Long-term Treatment With Multiple Transfusions and Chelation Therapy
1987
Human adipocytes secrete mineralocorticoid-releasing factors
2003
Neuroendocrine Control of Growth Hormone Secretion
1999
Resistant Hypertension: Diagnosis, Evaluation, and Treatment
2008 Standout
Works of Sandro Loche being referenced
REDUCED GROWTH HORMONE RESPONSE TO GROWTH HORMONE‐RELEASING HORMONE IN CHILDREN WITH SIMPLE OBESITY: EVIDENCE FOR SOMATOMEDIN‐C MEDIATED INHIBITION
1987
Secretion of growth hormone releasing hormone in obese children
1992
Severe impairment of bone mass and turnover in Cushing’s disease: comparison between childhood‐onset and adulthood‐onset disease
2002
Epinephrine Mediates the Growth Hormone-Releasing Effect of Galanin in Infant Rats*
1988
The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto’s thyroiditis and isolated hyperthyrotropinaemia: a 3‐year follow‐up
2011
Interaction of free fatty acids and arginine on growth hormone secretion in man
1994
Thyroid Function in Obese Children and Adolescents
2010
Bone Loss Is Correlated to the Severity of Growth Hormone Deficiency in Adult Patients with Hypopituitarism1
1999
THE EFFECT OF GALANIN ON BASELINE AND GHRH‐INDUCED GROWTH HORMONE SECRETION IN OBESE CHILDREN
1990
Characterization of thyroglobulin epitopes in Sardinian adults and juveniles with Hashimoto’s thyroiditis: evidence against a major effect of age and genetic background on B‐cell epitopes
2009
The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life
2010
Pyridostigmine Potentiates L-Dopa- but not Arginine- and Galanin-Induced Growth Hormone Secretion in Children
1990
Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic–pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests
2005
Thyroid Morphology and Subclinical Hypothyroidism in Children and Adolescents with Williams Syndrome
2006
Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man
1993
Exogenous growth hormone administration does not inhibit the growth hormone response to hexarelin in normal men
1995
Pyridostigmine counteracts the blunted growth hormone response to growth hormone-releasing hormone of obese children
1989
Oral administration of arginine enhances the growth hormone response to growth hormone releasing hormone in short children
1993
Evidence for Involvement of Endogenous Somatostatin in the Galanin-Induced Growth Hormone Secretion in Children
1990
Mutations in the vasopressin V2-receptor gene in three families of Italian descent with nephrogenic diabetes insipidus
1994
Effect of long‐term growth hormone treatment on carbohydrate metabolism in children with growth hormone deficiency
1998
Effect of 2 years of cortisol normalization on the impaired bone mass and turnover in adolescent and adult patients with Cushing's disease: a prospective study
2003
The Effects of Galanin on Growth Hormone Secretion in Children of Normal and Short Stature1
1989
The growth hormone-releasing activity of hexarelin, a new synthetic hexapeptide, in short normal and obese children and in hypopituitary subjects.
1995
Short-term met-hGH infusion inhibits somatotroph response to growth hormone releasing hormone (1–44)
1988
The Growth Hormone (GH) Response to the Arginine Plus GH-Releasing Hormone Test Is Correlated to the Severity of Lipid Profile Abnormalities in Adult Patients with GH Deficiency
1999
Growth hormone (GH) autofeedback action in the neonatal rat: involvement of GH-releasing hormone and somatostatin
1990
A Child with Phenotypic Laron Dwarfism and Normal Somatomedin Levels
1989
Synergistic effect of growth hormone-releasing hormone (GHRH) and clonidine in stimulating GH release in young and old dogs
1990
Involvement of Brain Catecholamines and Acetylcholine in Growth Hormone Deficiency States
1991
Augmentation of Growth Hormone Secretion in Children With Constitutional Growth Delay by Short Term Clonidine Administration: A Pulse Amplitude-Modulated Phenomenon*
1989
Naloxone-Induced Luteinizing Hormone Secretion in Normal, Precocious, and Delayed Puberty*
1986
Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children.
1996
Potentiation of Cholinergic Tone Counteracts the Suppressive Effect of Oral Glucose Administration on the GH Response to GHRH in Man
1989
CLONIDINE ACCELERATES GROWTH IN CHILDREN WITH IMPAIRED GROWTH HORMONE SECRETION
1985
Adrenal Androgens in Obese Boys before and after Weight Loss
1984
The growth hormone response to hexarelin in patients with Prader-Willi syndrome
1998
THE EFFECT OF OXANDROLONE ON THE GROWTH HORMONE RESPONSE TO GROWTH HORMONE RELEASING HORMONE IN CHILDREN WITH CONSTITUTIONAL GROWTH DELAY
1986
CLONIDINE TREATMENT FOR SHORT STATURE
1987
The effect of hexarelin on growth hormone (GH) secretion in patients with GH deficiency.
1995
The Growth Hormone Response to Hexarelin in Children: Reproducibility and Effect of Sex Steroids1
1997
Prolactinomas in Children and Adolescents. Clinical Presentation and Long-Term Follow-Up
1998
Sexual maturation and adrenal function in girls with thalassemia
1984
The GH/IGF-I axis in puberty.
1996